✦ LIBER ✦

Epitope selection and development of peptide based vaccines to treat cancer

✍ Scribed by Esteban Celis; Alessandro Sette; Howard M. Grey

Book ID: 113408914
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 708 KB
Volume: 6
Category: Article
ISSN: 1044-579X
DOI: 10.1016/1044-579x(95)90002-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of peptide selection approach

Evaluation of peptide selection approaches for epitope-based vaccine design

✍ Schubert, B.; Lund, O.; Nielsen, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 601 KB

Development of an epitope conservancy an

Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines

✍ Huynh-Hoa Bui; John Sidney; Wei Li; Nicolas Fusseder; Alessandro Sette 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 864 KB

Cell-Free Tumor Antigen Peptide-Based Ca

Cell-Free Tumor Antigen Peptide-Based Cancer Vaccines

✍ Walter Schmidt, Michael Buschle, Wolfgang Zauner, Helen Kirlappos, Karl Mechtler 📂 Article 📅 1997 🏛 National Academy of Sciences 🌐 English ⚖ 990 KB

Epitope Selection and Design of Syntheti

Epitope Selection and Design of Synthetic Vaccines Molecular Approaches to Enhancing Immunogenicity and Cross-Reactivity of Engineered Vaccines

✍ JAY A. BERZOFSKY 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

Development of a cancer vaccine: peptide

Development of a cancer vaccine: peptides, proteins, and DNA

✍ Shiku, Hiroshi; Wang, Lijie; Ikuta, Yasushi; Okugawa, Toshiharu; Schmitt, Michae 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 114 KB

Random-peptide libraries and antigen-fra

Random-peptide libraries and antigen-fragment libraries for epitope mapping and the development of vaccines and diagnostics

✍ Melita B Irving; Oscar Pan; Jamie K Scott 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Random peptide libraries and antigen-fragment libraries (also known as gene-fragment libraries) have been used to identify epitopes on protein antigens. These technologies promise to make significant contributions to diagnostic and vaccine development. Researchers in a number of labs have shown that